2 suspended, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Suspended 2 |
Follow Nanogen, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prospective Evaluation of the Fluid Rapid Influenza Test fluID Rapid Influenza Test - Influenza | Phase 3 | Suspended | Nanogen, Inc. | 1300 | 2009-02-01 | 2009-04-15 |
| Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B fluID Rapid Influenza Test, BinaxNOW® Influenza A & B - Influenza | Phase 3 | Suspended | Nanogen, Inc. | 650 | 2009-02-01 | 2009-03-06 |
| Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples Congestive Heart Failure (CHF) | Completed | Nanogen, Inc. | 450 | 2008-02-01 | 2008-12-10 |
Influenza, Human (2) · Heart Failure (1)
United States (3) · Hong Kong (1)
Alan Maisel, MD (1) · Alan Wu, PhD (1)